Louis, Paris, France, 7 CHU de Lille, Univ Lille, INSERM U 1286, Infinite, Lille, France, 8 Gustave Roussy Cancer Campus, BMT Service, Villejuif, France, 9 University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany, 10 Manchester Royal Infirmary, Manchester, United Kingdom, 11 University Medical Center Groningen (UMCG), University of Groningen, Groningen, Netherlands, 12 Cliniques Universitaires St. Measurable Residual Disease, FLT3-ITD Mutation And Disease Status Have Independent Prognostic Influence on Post-Transplant Outcomes in NPM1-Mutated Acute Myeloid Leukemia Rama Al Hamed 1,2, Myriam Labopin 2, Eric Deconinck 3, Riitta Niittyvuopio 4, Anne Huynh 5, Gerard Socié 6, Ibrahim Yakoub-Agha 7, Jean Henri Bourhis 8, Hassan Naim 9, Eleni Tholouli 10, Goda Choi 11, Xavier Poiré 12, Hans Martin 13, Marie-Thérèse Rubio 14, Pavel Jindra 15, Didier Blaise 16, Dietrich Beelen 17, Hélène Labussière-Wallet 18, Jordi Esteve 19, Arnon Nagler 20, Ali Bazarbachi 21, Mohamad Mohty 22 1 Jacobi Medical Center-Albert Einstein College of Medicine, The Bronx, United States, 2 EBMT Paris Office, CEREST-TC, Saint Antoine Hospital, Paris, France, 3 Hôpital Jean Minjoz, Service d`Hématologie, Besacon, France, 4 HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland, 5 CHU IUCT-O, Toulouse, France, 6 Hôpital St.

Nonmem ebv